Rhythm Pharmaceuticals (RYTM) delivered earnings and revenue surprises of 8.75% and 2.36%, respectively, for the quarter ended September 2024. Do the...
Vous n'êtes pas connecté
Syndax (SNDX) delivered earnings and revenue surprises of 13.27% and 96.85%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Rhythm Pharmaceuticals (RYTM) delivered earnings and revenue surprises of 8.75% and 2.36%, respectively, for the quarter ended September 2024. Do the...
Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 18.10% and 3.88%, respectively, for the quarter ended September 2024. Do the...
Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of 4.55% and 4.59%, respectively, for the quarter ended September 2024. Do the...
Urogen Pharma (URGN) delivered earnings and revenue surprises of 34.52% and 4.06%, respectively, for the quarter ended September 2024. Do the numbers...
Aadi Bioscience (AADI) delivered earnings and revenue surprises of 0% and 10.11%, respectively, for the quarter ended September 2024. Do the numbers...
National CineMedia (NCMI) delivered earnings and revenue surprises of -33.33% and 7.22%, respectively, for the quarter ended September 2024. Do the...
Lumen (LUMN) delivered earnings and revenue surprises of 35% and 0.58%, respectively, for the quarter ended September 2024. Do the numbers hold clues...
Ultragenyx (RARE) delivered earnings and revenue surprises of 3.45% and 4.04%, respectively, for the quarter ended September 2024. Do the numbers hold...
AnaptysBio (ANAB) delivered earnings and revenue surprises of 33.72% and 279.19%, respectively, for the quarter ended September 2024. Do the numbers...
Frontier Communications (FYBR) delivered earnings and revenue surprises of -50% and 2.35%, respectively, for the quarter ended September 2024. Do the...